[1]
Blavatska О. et al. 2026. Use of ranibizumab for the treatment of subretinal neovascularization in pathologic myopia: a prospective study. Ukrainian Journal of Ophthalmology . 3 (Jun. 2026), 10–14. DOI:https://doi.org/10.31288/oftalmolzh201631014.